Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Lino AMM, Spera RR, de Campos FPF, Freitas CHA, Garcia MRT, Lopes LDC, Prokopowitsch AS.

Autops Case Rep. 2014 Mar 31;4(1):29-37. doi: 10.4322/acr.2014.005. eCollection 2014 Jan-Mar.

2.

Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report.

Bîrluţiu V, Bîrluţiu RM.

J Med Case Rep. 2014 Jun 26;8:232. doi: 10.1186/1752-1947-8-232.

3.

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.

Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, Muscal E, Deiva K, Andersen E, Eyre MR, Eleftheriou D, Brogan PA, Kneen R, Alper G, Anlar B, Wassmer E, Heineman K, Hemingway C, Riney CJ, Kornberg A, Tardieu M, Stocco A, Banwell B, Gorman MP, Benseler SM, Lim M.

Neurology. 2014 Jul 8;83(2):142-50. doi: 10.1212/WNL.0000000000000570. Epub 2014 Jun 11.

4.

Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system.

Salmen A, Gold R, Chan A.

Clin Exp Immunol. 2014 May;176(2):135-48. doi: 10.1111/cei.12258. Review.

5.

Clinical responses to rituximab in a case of neuroblastoma with refractory opsoclonus myoclonus ataxia syndrome.

Alavi S, Kord Valeshabad A, Moradveisi B, Aminasnafi A, Arzanian MT.

Case Rep Oncol Med. 2012;2012:164082. doi: 10.1155/2012/164082. Epub 2012 Nov 6.

6.

Advances in human B cell phenotypic profiling.

Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I.

Front Immunol. 2012 Oct 10;3:302. doi: 10.3389/fimmu.2012.00302. eCollection 2012.

7.

Practical considerations on the use of rituximab in autoimmune neurological disorders.

Kosmidis ML, Dalakas MC.

Ther Adv Neurol Disord. 2010 Mar;3(2):93-105. doi: 10.1177/1756285609356135.

8.

Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.

Hollenbeck R, Black BK, Peltier AC, Biaggioni I, Robertson D, Winton EF, Raj SR.

Arch Neurol. 2011 Mar;68(3):372-5. doi: 10.1001/archneurol.2010.289. Epub 2010 Nov 8.

9.

Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome.

Paz-Priel I, Cooke DW, Chen AR.

J Pediatr. 2011 Feb;158(2):337-9. doi: 10.1016/j.jpeds.2010.07.006. Epub 2010 Aug 21.

10.

Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.

Wong-Kisiel LC, Ji T, Renaud DL, Kotagal S, Patterson MC, Dalmau J, Mack KJ.

Neurology. 2010 May 11;74(19):1550-1. doi: 10.1212/WNL.0b013e3181dd41a1. No abstract available.

11.

Paraneoplastic limbic encephalitis presenting as a neurological emergency: a case report.

Xia Z, Mehta BP, Ropper AH, Kesari S.

J Med Case Rep. 2010 Mar 24;4:95. doi: 10.1186/1752-1947-4-95.

12.

Paraneoplastic syndromes of the CNS.

Dalmau J, Rosenfeld MR.

Lancet Neurol. 2008 Apr;7(4):327-40. doi: 10.1016/S1474-4422(08)70060-7. Review.

Supplemental Content

Support Center